<DOC>
	<DOCNO>NCT01079078</DOCNO>
	<brief_summary>The study conduct open label , balance , randomise , two-treatment , two-period , two-sequence , single dose , crossover bioavailability study compare acetaminophen extend release gelcaps 650 mg ( contain acetaminophen 650 mg ) OHM Laboratories Inc. TYLENOLÃ’ arthritis pain caplets 650 mg ( contain acetaminophen 650 mg ) McNeil Consumer &amp; specialty Pharmaceuticals healthy , adult , human , male subject feed condition .</brief_summary>
	<brief_title>A Relative Bioavailability Study Acetaminophen 650 mg Extended Release Gelcaps Under Fed Condition</brief_title>
	<detailed_description>A single oral dose acetaminophen 650 mg administer ( except Subject No . 17 ) 240 mL drinking water period supervision train study personnel . During course study , safety parameter assess vital sign , clinical examination , medical history clinical laboratory safety test ( hematology , biochemical , serology parameter urine analysis ) base line . Laboratory parameter hematology biochemistry repeat end study ( except Glucose cholesterol ) .</detailed_description>
	<mesh_term>Acetaminophen</mesh_term>
	<criteria>Were age range 1845 year . Were neither overweight underweight correspond height per Life Insurance Corporation India height/weight chart nonmedical case . Had voluntarily give write informed consent participate study . Were normal health determine medical history physical examination subject perform within 21 day prior commencement study . Were nonvegetarian . There deviation regard . Had history hypersensitivity acetaminophen component formulation . Had history skin rash , thrombocytopenia , urticaria angioedema . Had history peptic ulcer . Had recent history nausea vomit Showed evidence organ dysfunction clinically significant deviation normal , physical clinical determination . Showed presence disease marker HIV 1 2 , Hepatitis B C viruses syphilis infection . Showed presence value significantly different normal reference range define and/or judge clinically significant haemoglobin , total white blood cell count , differential WBC count platelet count . Were positive urinary screen test drug abuse ( opiates cannabinoids ) Showed presence value significantly different normal reference range and/or judge clinically significant serum creatinine , blood urea nitrogen , serum aspartate aminotransferase ( AST ) , serum alanine aminotransferase ( ALT ) , serum alkaline phosphatase , serum bilirubin , plasma glucose serum cholesterol . Showed clinically abnormal chemical microscopic examination urine define presence RBC , WBC ( &gt; 4/HPF ) , epithelial cell ( &gt; 4/HPF ) , glucose ( positive ) protein ( positive ) . Showed clinically abnormal ECG Chest Xray . Had history serious gastrointestinal , hepatic , renal , cardiovascular , pulmonary , neurological haematological disease , diabetes glaucoma . Had history psychiatric illness , might impair ability provide write informed consent . Were regular smoker smoke 10 cigarette daily difficulty abstain smoke duration study period . Had history drug dependence excessive alcohol intake habitual basis 2 unit alcoholic beverage per day ( 1 unit equivalent half pint beer 1 glass wine 1 measure spirit ) difficulty abstain duration study period . Used enzyme modify drug within 30 day prior Day 1 study . Participated clinical trial within 12 week precede Day 1 study . Subjects , completion study , donate and/or lose 350 mL blood past 3 month . There deviation regard .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>March 2010</verification_date>
	<keyword>Acetaminophen feed study</keyword>
</DOC>